Brown University Health

Brown University Health

Formed in 1994 as Lifespan, Brown University Health is Rhode Island’s dominant not-for-profit academic health system. It owns and operates seven hospital campuses — including Rhode Island Hospital, The Miriam Hospital, and Newport Hospital — plus outpatient centers and physician practices that stretch into southeastern Massachusetts. The system serves as the primary teaching site for the Warren Alpert Medical School of Brown University, which in 2024 deepened the integration with a $150 million investment commitment spread over seven years. The health system’s balance sheet pools operating-entity cash and a modest endowment estimated at roughly $563 million (Altss estimate). Allocations extend beyond traditional fixed income: disclosed exchange-traded fund positions include Bitcoin and gold exposure, unusual for a hospital treasury. The physical portfolio anchors the asset base, with eight owned medical campuses, a helicopter fleet at Rhode Island Hospital, and commercial mixed-use holdings in Providence’s Jewelry District and across Connecticut. Bilateral research partnerships with Care New England add clinical deal-flow density. Samuel Mencoff, co-founder of Chicago private-equity firm Madison Dearborn Partners, governs as board chair — a structure that imports private-markets governance into a non-profit operating company. Lawrence Aubin Sr., the founding chair, remains a legacy figure. Team size is not publicly disclosed, nor is the name of the chief investment officer. In recent months, the system finalized its rebrand from Lifespan to Brown University Health to signal the academic affiliation, cementing a strategic identity shift timed to the university’s capital pledge. Unlike a university endowment that exists solely to fund the academic mission, this balance sheet is inseparable from the operating enterprise — cash flows from patient care, research grants, and tuition reimbursement wash through the same pool that funds ETF allocations. That hybrid operating-company-plus-investment-office architecture is rare among mid-sized hospital systems and places pressure on treasury liquidity management distinct from a pure allocator.